S. A. Danner

4.1k citations

46 papers · 2.6k indexed · h-index 21

Virology top 0.2%
- HIV Research and Treatment 18
Infectious Diseases top 1%
- HIV/AIDS drug development and treatment 15
- HIV/AIDS Research and Interventions 11
Emergency Medicine top 2%
- HIV-related health complications and treatments 5
Immunology top 5%
- Immunodeficiency and Autoimmune Disorders 7
- T-cell and Retrovirus Studies 3
Hepatology top 5%
Epidemiology
- Pneumocystis jirovecii pneumonia detection and treatment 10
- Cytomegalovirus and herpesvirus research 7

Co-authors: Joep M. A. Lange Jaap Goudsmit Jan Karel M. Eeftinck Schattenkerk R A Coutinho J. van der Noordaa F. de Wolf Frank Miedema Marijke Roos
Cited by: Virology Infectious Diseases Emergency Medicine
Journals: Clinical Infectious Diseases (3 papers)British Journal of Haematology (2 papers)Journal of Clinical Investigation (2 papers)
Partner nations: Netherlands Vietnam Italy

In The Last Decade

S. A. Danner

44 papers receiving 2.5k citations

Peers

Countries citing papers authored by S. A. Danner

Since Specialization

Citations

This map shows the geographic impact of S. A. Danner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. A. Danner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. A. Danner more than expected).

Fields of papers citing papers by S. A. Danner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. A. Danner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. A. Danner. The network helps show where S. A. Danner may publish in the future.

Co-authorship network

The 25 scholars most cited alongside S. A. Danner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with S. A. Danner Line = papers co-authored together S. A. Danner links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Acquired Immune Deficiency Syndrome, Altered T Cell Subset Ratios, and Cytomegalovirus Infections among Male Homosexuals in The Netherlands Antibiotics and chemotherapy/Antibiotica et chemotherapia ·Jaap Goudsmit,P. Wertheim‐van Dillen,P. T. A. Schellekens,R A Coutinho,S. A. Danner,J. van der Noordaa	2015	0
2	The Second-Generation Active A Immunotherapy CAD106 Reduces Amyloid Accumulation in APP Transgenic Mice While Minimizing Potential Side Effects Journal of Neuroscience ·Christoph Wießner,Karl‐Heinz Wiederhold,Alain C. Tissot,Pascal Frey,S. A. Danner,Laura H. Jacobson,Gary T. Jennings,Rainer M. Lüönd,R. Ortmann,Julia Reichwald,Mauro Zurini,Anis K. Mir,Martin F. Bachmann,M. Staufenbiel	2011	149
3	Protease inhibitors atazanavir, lopinavir and ritonavir are potent blockers, but poor substrates, of ABC transporters in a broad panel of ABC transporter-overexpressing cell lines Journal of Antimicrobial Chemotherapy ·Wouter F.W. Bierman,George L. Scheffer,Adriane Reis de Araujo,Gerrit Jansen,Michiel A. van Agtmael,S. A. Danner,Rik J. Scheper	2010	66
4	Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV-1 infection AIDS ·Marc van der Valk,Elizabeth H. Gisolf,Peter Reiss,Ferdinand W.N.M. Wit,Anthony J. Japour,Gerrit Jan Weverling,S. A. Danner	2001	132
5	No Beneficial Effect of Interferon- Treatment in 2 Human Immunodeficiency Virus-Infected Patients with Mycobacterium avium Complex Infection Clinical Infectious Diseases ·Fanny N. Lauw,Jan T. M. van der Meer,Jesse de Metz,S. A. Danner,Tom van der Poll	2001	13
6	Risk Factors for Hepatotoxicity in HIV-1--Infected Patients Receiving Ritonavir and Saquinavir with or without Stavudine Clinical Infectious Diseases ·Elizabeth H. Gisolf,Christa Dreezen,S. A. Danner,Ю О Семиреч,Gerrit Jan Weverling,(unknown)	2000	75
7	Conversion Rate towards a Syncytium‐Inducing (SI) Phenotype during Different Stages of Human Immunodeficiency Virus Type 1 Infection and Prognostic Value of SI Phenotype for Survival after AIDS Diagnosis The Journal of Infectious Diseases ·M. Koot,(unknown),R. E. Y. de Goede,Ireneus P.M. Keet,S. A. Danner,Jan Karel M. Eeftinck Schattenkerk,Peter Reiss,M Tersmette,J. M. A. Lange,Hanneke Schuitemaker	1999	82
8	Effects of protease inhibitors on the course of CMV retinitis in relation to CD4+ lymphocyte responses in HIV+ patients British Journal of Ophthalmology ·G. J. van den Horn,Christina Meenken,S. A. Danner,(unknown),Marc D. de Smet	1998	25
9	Impact of diarrhoea and faecal incontinence on the daily life of HIV-infected patients AIDS Care ·Fransje Snijders,Josien B. de Boer,Bert Steenbergen,H. Schnörer,S. A. Danner,F.S.A.M. van Dam	1998	11
10	Selective inhibition of syncytium-inducing and nonsyncytium-inducing HIV-1 variants in individuals receiving didanosine or zidovudine, respectively. Journal of Clinical Investigation ·Angélique B. van ’t Wout,Mida Lishanata Simatupang,Menno D. de Jong,Margreet Bakker,Remko van Leeuwen,Daan W. Notermans,A Loeliger,F. de Wolf,S. A. Danner,Peter Reiss,Charles A. Boucher,Joep M. A. Lange,Hanneke Schuitemaker	1997	22
11	Factors Associated with the Development of Pneumocystis carinii Pneumonia in 5,025 European Patients with AIDS Clinical Infectious Diseases ·Jens Lundgren,Simon Barton,Adriano Lazzarin,S. A. Danner,F. D. Goebel,Ilias Mastoris,F Mulcahy,J. Kosmidis,C Pedersen,Andrew Phillips,(unknown)	1995	24
12	Rapid Changes in Human Immunodeficiency Virus Type 1 RNA Load and Appearance of Drug-Resistant Virus Populations in Persons Treated with Lamivudine (3TC) The Journal of Infectious Diseases ·Rob Schuurman,Monique Nijhuis,Remko van Leeuwen,P Schipper,Daphne de Jong,P. Collis,S. A. Danner,Jan W. Mulder,Clive Loveday,Cindy Christopherson,Shirley Kwok,John J. Sninsky,Charles A. Boucher	1995	417
13	General operative aspects of human immunodeficiency virus infection and acquired immunodeficiency syndrome. PubMed ·Esther C. J. Consten,J. Jan B. van Lanschot,C. P. Henny,J. F. M. Slors,S. A. Danner,W. H. Brummelkamp	1995	7
14	Combined zidovudine and interferon‐alpha treatment in patients with AIDS‐associated Kaposi's sarcoma Journal of Internal Medicine ·Ronald de Wit,S. A. Danner,Piet Bakker,Joep M. A. Lange,Jan Karel M. Eeftinck Schattenkerk,C.H.N. Veenhof	1991	25
15	Can the course of high dose cotrimoxazole for Pneumocystis carinii pneumonia in AIDS be shorter? A possible solution to the problem of cotrimoxazole toxicity Journal of Internal Medicine ·Jan Karel M. Eeftinck Schattenkerk,Joep M. A. Lange,Reindert P. van Steenwijk,S. A. Danner	1990	12
16	Declining incidence of AIDS dementia complex after introduction of zidovudine treatment. BMJ ·Peter Portegies,Jan de Gans,Joep M. A. Lange,M.M.A. Derix,Hans Speelman,Margreet Bakker,S. A. Danner,Jaap Goudsmit	1989	172
17	Cellular and humoral immunity in various cohorts of male homosexuals in relation to infection with human immunodeficiency virus. Data Archiving and Networked Services (DANS) ·Swan RJ,Frank Miedema,Jan Karel M. Eeftinck Schattenkerk,F de Wolf,Jaap Goudsmit,Joep M. A. Lange,S. A. Danner,T.A. Out,P T Schellekens	1989	8
18	Ziekteverschijnselen en klinisch beloop bij de eerste honderd patiënten met AIDS Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank ·S. A. Danner,M. Siedek,Joep M. A. Lange,Reindert P. van Steenwijk,Jan de Gans,Robert Zagitov,David James Watson	1987	1
19	Autoimmunity against blood cells in human immunodeficiency-virus (HIV) infection British Journal of Haematology ·J. van der Lelie,Joep M. A. Lange,Alex Solà,C. M. van Dalen,S. A. Danner,Henry P. Murphy	1987	75
20	Distinct IgG recognition patterns during progression of subclinical and clinical infection with lymphadenopathy associated virus/human T lymphotropic virus. BMJ ·Joep M. A. Lange,R A Coutinho,W Krone,M Hasanian Mehr,S. A. Danner,J. van der Noordaa,Jaap Goudsmit	1986	140

About S. A. Danner

S. A. Danner is a scholar working on Virology, Infectious Diseases, Immunology, Epidemiology and Emergency Medicine, having authored 46 papers that have together received 2.6k indexed citations. Recurring topics across this work include HIV Research and Treatment (18 papers), HIV/AIDS drug development and treatment (15 papers), HIV/AIDS Research and Interventions (11 papers), Pneumocystis jirovecii pneumonia detection and treatment (10 papers), Immunodeficiency and Autoimmune Disorders (7 papers), Cytomegalovirus and herpesvirus research (7 papers), HIV-related health complications and treatments (5 papers) and T-cell and Retrovirus Studies (3 papers). The work is most often cited by research in Virology (1.7k citations), Infectious Diseases (1.4k citations), Emergency Medicine (352 citations), Immunology (551 citations) and Hepatology (148 citations). S. A. Danner has collaborated with scholars based in Netherlands, Vietnam and Italy. Frequent co-authors include Joep M. A. Lange, Jaap Goudsmit, Jan Karel M. Eeftinck Schattenkerk, Jaap Goudsmit, R A Coutinho, J. van der Noordaa, F. de Wolf, Frank Miedema, Marijke Roos and Fokke G. Terpstra. Their work appears in journals such as Clinical Infectious Diseases, British Journal of Haematology, Journal of Clinical Investigation, AIDS and Journal of Internal Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact